Moderna Inc (MRNA : NASDAQ)
Common Stock
$220.83
USD
-0.89 (-0.40%)
Last updated: 2026-11-02
Follow MRNA
MRNA
Moderna Inc
WealthAwesomePerformance
1 Day
-0.40%
1 Week
+11.05%
1 Month
+16.22%
YTD
+615.59%
Key Statistics
Market Cap
$88.16B
52W High
$254.48
52W Low
$22.28
P/E Ratio
-
50 Day MA
$182.49
200 Day MA
$86.58
Beta
1.17
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/2/2026 | $224.16 | $230.52 | $217.62 | $220.83 | $220.83 | 8,440,799 |
| 10/30/2026 | $220.53 | $227.81 | $217.22 | $221.72 | $221.72 | 8,999,800 |
| 10/29/2026 | $216.43 | $225.00 | $215.35 | $222.76 | $222.76 | 10,834,628 |
| 10/28/2026 | $204.00 | $218.16 | $202.62 | $214.16 | $214.16 | 12,038,620 |
| 10/27/2026 | $192.23 | $208.87 | $179.53 | $207.97 | $207.97 | 17,638,151 |
| 10/26/2026 | $186.90 | $203.82 | $181.65 | $198.85 | $198.85 | 17,108,669 |
| 10/23/2026 | $196.69 | $206.97 | $183.00 | $200.10 | $200.10 | 21,524,700 |
| 10/22/2026 | $240.13 | $241.26 | $180.80 | $202.63 | $202.63 | 49,947,211 |
| 10/21/2026 | $242.20 | $254.48 | $239.55 | $245.81 | $245.81 | 16,009,396 |
| 10/20/2026 | $226.03 | $243.98 | $216.65 | $242.08 | $242.08 | 16,858,882 |
Analyst Price Targets
Based on 23 analysts covering MRNA · as of Nov 2, 2026
Wall Street analysts forecast MRNA stock price to fall 37.3% over the next 12 months.
Consensus
Hold3.09 / 5.00
Avg. Target
US$138.37
-37.3% Upside
Current Price
US$220.83
Last close
Analyst Breakdown (23 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MRNA's historical volatility
30-Day Vol
94.5%
Annualized
90-Day Vol
195.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$264.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$234.37 | US$169.19 – US$324.67 |
| 60 trading days | US$248.75 | US$156.89 – US$394.38 |
| 90 trading days | US$264.00 | US$150.13 – US$464.25 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Moderna Inc
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Financials
- Revenue (TTM)
- $2.23B
- EBITDA
- $-2.20B
- Profit Margin
- -141.43%
- ROE (TTM)
- -39.00%
- EPS (Diluted)
- -7.98
- Book Value
- 16.95
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About MRNA.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| VCIG | VCI Global Limited Ordinary Share | $8.16 | +4728.40% |
| RETO | ReTo Eco-Solutions Inc | $4.16 | +647.26% |
| BJDX | Bluejay Diagnostics Inc | $2.12 | +281.02% |
| INO | Inovio Pharmaceuticals Inc | $1.89 | +215.00% |
| CLRO | ClearOne Inc | $5.65 | +65.69% |
| INLF | INLIF LIMITED Ordinary Shares | $0.29 | +56.76% |
| AMPGZ | Amplitech Group, Inc. Series B Right | $0.06 | +55.50% |
| GENVR | Gen Digital Inc. Contingent Value Rights | $2.85 | +52.41% |
MRNA.US news timeline
15 articles covering MRNA.US, most recent first
LatestModerna Is Up 11.9% This Week. What's Behind the Move?
October 2026
- Why Moderna stock went up yesterday
- Why Moderna stock is gaining today
- Why Moderna stock plummeted yesterday
- Why Moderna stock surged yesterday
- Why Moderna stock is skyrocketing today
- Why Moderna stock went up yesterday
- Why Moderna stock plummeted yesterday
- Why Moderna stock is plummeting today
- Why Moderna stock is rising today
- Why Moderna stock is sliding today
- Why Moderna stock plummeted yesterday